Clinical Trials in Illinois

Showing 5141-5160 of 19,692 trials

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

NCT03999996

The purpose of this study is to describe antibody persistence for each of the 4 dengue serotypes for up to 63 months after the first vaccination in the primary vaccination series for participants from parent trial DEN-315 (NCT03341637) (Mexico) and for up to 36 months after the first vaccination in the primary vaccination series for participants from parent trial DEN-304 (NCT03423173) (United States \[US\]) and to describe the impact of a tetravalent dengue vaccine (TDV) booster dose vs placebo on antibody response for each of the 4 dengue serotypes at 1 month and 6 months post administration of the TDV booster or placebo.

Dengue Fever

Takeda365 participantsStarted Nov 2019

Huntsville, Alabama, United States • Peoria, Illinois, United States • Newton, Kansas, United States +7 more locations

COMPLETEDPhase 3115 miles

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

NCT05393895

This is a multi-center, double-masked, vehicle-controlled study. The purpose of the study is to evaluate the safety of CSF-1 compared with vehicle in presbyopic subjects. Subjects will be treated for at least 6 weeks.

Presbyopia

Orasis Pharmaceuticals Ltd.178 participantsStarted Apr 2022

Newport Beach, California, United States • Petaluma, California, United States • Colorado Springs, Colorado, United States +9 more locations

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

Find Trials by Condition in Illinois

Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer

Multi-Center Study of ManNAc for GNE Myopathy

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)

A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

AVID100 in Advanced Epithelial Carcinomas

A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic

Natural History Study of Synucleinopathies

Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis

ALL Adult Consortium Trial: Adult ALL Trial

AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.